Document is current
Any future updates will be listed below
-
Authors
Nouailles, Geraldine https://orcid.org/0000-0003-1973-3119
Adler, Julia M. https://orcid.org/0000-0001-8147-0351
Pennitz, Peter https://orcid.org/0000-0002-8132-7237
Peidli, Stefan https://orcid.org/0000-0002-4257-8690
Teixeira Alves, Luiz Gustavo https://orcid.org/0000-0002-5822-4168
Baumgardt, Morris https://orcid.org/0000-0003-2077-3716
Bushe, Judith
Voss, Anne
Langenhagen, Alina
Langner, Christine https://orcid.org/0000-0001-7311-3477
Martin Vidal, Ricardo https://orcid.org/0000-0002-9670-5640
Pott, Fabian https://orcid.org/0000-0003-3700-1691
Kazmierski, Julia https://orcid.org/0000-0002-7962-2165
Ebenig, Aileen https://orcid.org/0000-0001-7066-0184
Lange, Mona V.
Mühlebach, Michael D. https://orcid.org/0000-0002-7069-5018
Goekeri, Cengiz https://orcid.org/0000-0002-1616-4005
Simmons, Szandor
Xing, Na
Abdelgawad, Azza
Herwig, Susanne
Cichon, Günter
Niemeyer, Daniela https://orcid.org/0000-0002-1897-6365
Drosten, Christian https://orcid.org/0000-0001-7923-0519
Goffinet, Christine https://orcid.org/0000-0002-3959-004X
Landthaler, Markus https://orcid.org/0000-0002-1075-8734
Blüthgen, Nils https://orcid.org/0000-0002-0171-7447
Wu, Haibo
Witzenrath, Martin
Gruber, Achim D. https://orcid.org/0000-0002-4502-0393
Praktiknjo, Samantha D. https://orcid.org/0000-0002-0186-5271
Osterrieder, Nikolaus
Wyler, Emanuel https://orcid.org/0000-0002-9884-1806
Kunec, Dusan
Trimpert, Jakob https://orcid.org/0000-0003-1616-0810
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB 1449–431232613, SFB TR84, SFB 1449–431232613, SFB TR84, OS 143/16-1, SFB TR84)
Bundesministerium für Bildung und Forschung (16GW0247, 01ZX1604B, 01ZX1906A, 16GW0247, Organo-Strat 01KX2021)
Bundesministerium für Gesundheit (CHARIS 6a)
Helmholtz Association (KA1-Co-02, KA1-Co-02)
Einstein Stiftung Berlin (EZ-2020-597 FU)
- License Information
-
More Information
Article History
Received: 30 June 2022
Accepted: 1 March 2023
First Online: 3 April 2023
Competing interests
: Related to this work, Freie Universität Berlin has filed a patent application (FU227EP - 22193939.0- 1111, Freie Universität Berlin, Germany) for the use of sCPD9 as vaccine in humans. In this application, J.T., N.O. and D.K. are named as inventors of sCPD9. Freie Universität Berlin is collaborating with RocketVax Inc. for further development of sCPD9 and receives funding for research. Independent of this work, G.N. has received project funding from Biotest AG; and M.W. received funding for research from Bayer Health Care, Biotest, Pantherna and Vaxxilon, and for lectures and advisorship from Alexion, Aptarion, Astra Zeneca, Bayer Health Care, Berlin Chemie, Biotest, Boehringer Ingelheim, Chiesi, Glaxo Smith Kline, Insmed, Novartis, Teva and Vaxxilon. The other authors declare no competing interests.
